Deal Time! Smith & Nephew Snaps Up Leaf Healthcare For Wound Portfolio
Executive Summary
Smith & Nephew is continuing its acquisition spree by picking up Leaf Healthcare, the developer of a pressure injury prevention device, to bolster its advanced wound management portfolio.
You may also be interested in...
Device/Diagnostics Quarterly Dealmaking Statistics, Q2 2019
Device financing totaled $2.3bn for Q2 2019, with the debt category bringing in the most money. Merger and acquisition deals reached an aggregate $9.1bn (a 25% increase from Q1), thanks mostly to 3M’s $6.7bn takeover of Acelity and its KCI subsidiaries. Diagnostics/research financing, which totaled $2.4bn, showed a significant rise from the previous quarter, while diagnostics/research tools M&A values, at $233m, exhibited a steep decline.
2018 Earnings Spotlight: Stryker And Nuvasive Lead The Ortho Pack In 2018
Reported sales and earnings from the big publicly traded orthopedics device companies showed mostly slow growth in 2018, but NuVasive and Stryker reported high single-digit growth while, Smith & Nephew grew in the low single-digits, fueling reports that Smith & Nephew may try to buy NuVasive.